NEW YORK, Dec 18 (Reuters) - Cannae Holdings ( CNNE )
plans to hold talks about participating in a deal to acquire
Rapid7 ( RPD ) and will stop working with the activist investor
that has been urging the cybersecurity company to put itself up
for sale, according to a regulatory filing.
Hedge fund Jana Partners and publicly traded holding company
Cannae have "de-grouped" and will no longer be coordinating
actions with respect to Rapid7 ( RPD ), the firm said in the filing made
on Wednesday.
This step will allow Cannae to engage in confidential
discussions with Rapid7 ( RPD ) and other potential buyers without
involving Jana.
Jana has an economic interest of more than 12% and owns 5.8%
of voting shares of Rapid7 ( RPD ). Since June, when the activist first
unveiled its investment, Jana has been urging the
Boston-headquartered company to improve its operations and
forecasting and to consider selling itself.
Cannae, which is led by billionaire Bill Foley, currently
has operating interests in Dun & Bradstreet Holdings and Alight.
Jana said in a filing in June that it was working with Cannae
and that the plan was for Cannae to potentially participate in
an acquisition of the company.
Six weeks ago, Reuters reported that Rapid7 ( RPD ) was exploring
options with its investment bankers after attracting acquisition
interest from buyout firms, according to people familiar with
the matter. Goldman Sachs ( GS ) and JPMorgan ( JPM ) are
advising Rapid7 ( RPD ).
Rapid7 ( RPD ) specializes in so-called vulnerability management,
providing software tools and services that help businesses
assess and monitor security risks. The company has been forced
to compete harder for business as corporate clients cut back on
security spending due to broader macroeconomic uncertainty.
Its share price has fallen 29% since January.
Jana has previously pushed for the sale of New Relic, which
was taken private by TPG and Francisco Partners last year. It
also pushed for the sale of Zendesk, which was taken private in
2022 by investment firms led by Hellman & Friedman and Permira.